The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome
Open accessAbstract
Marfan syndrome is a connective tissue disorder caused by mutations in the gene encoding fibrillin-1 (FBN1). A dominant-negative mechanism has been inferred based upon dominant inheritance, mulitimerization of monomers to form microfibrils, and the dramatic paucity of matrix-incorporated fibrillin-1 seen in heterozygous patient samples. Yeast artificial chromosome-based transgenesis was used to overexpress a disease-associated mutant form of human fibrillin-1 (C1663R) on a normal mouse background. Remarkably, these mice failed to show any abnormalities of cellular or clinical phenotype despite regulated overexpression of mutant protein in relevant tissues and developmental stages and direct evidence that mouse and human fibrillin-1 interact with high efficiency. Immunostaining with a human-specific mAb provides what we believe to be the first demonstration that mutant fibrillin-1 can participate in productive microfibrillar assembly. Informatively, use of homologous recombination to generate mice heterozygous for a comparable missense mutation (C1039G) revealed impaired microfibrillar deposition, skeletal deformity, and progressive deterioration of aortic wall architecture, comparable to characteristics of the human condition. These data are consistent with a model that invokes haploinsufficiency for WT fibrillin-1, rather than production of mutant protein, as the primary determinant of failed microfibrillar assembly. In keeping with this model, introduction of a WT FBN1 transgene on a heterozygous C1039G background rescues aortic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Dietz, H. C., Cutting, C. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991) · Nature · doi:10.1038/352337a0 · Cited by 2,070
Self-citationDysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., & Dietz, H. C. (2003) · Nature Genetics · doi:10.1038/ng1116 · Cited by 1,404
Self-citationFibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.
Sakai, L. Y., Keene, D. R., & Engvall, E. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2499 · Cited by 1,157
Self-citationNonsense-mediated mRNA decayin health and disease
Frischmeyer, P. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1893 · Cited by 992
Life expectancy in the Marfan syndrome
Silverman, D. I., Burton, K. J., Gray, J., Bosner, M. S., Kouchoukos, N. T., Roman, M. J., Boxer, M., Devereux, R. B., & Tsipouras, P. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)80066-1 · Cited by 565
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1
Pereira, L., Lee, S. Y., Gayraud, B., Andrikopoulos, K., Shapiro, S. D., Bunton, T., Biery, N. J., Dietz, H. C., Sakai, L. Y., & Ramirez, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3819 · Cited by 549
Self-citationLife expectancy in the marfan syndrome
(1996) · ACC Current Journal Review · doi:10.1016/1062-1458(96)82279-3 · Cited by 481
THE FINE STRUCTURE OF ELASTIC FIBERS
Greenlee, T. K., Ross, R., & Hartman, J. L. (1966) · The Journal of Cell Biology · doi:10.1083/jcb.30.1.59 · Cited by 416
Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome
Pereira, L., Andrikopoulos, K., Tian, J., Lee, S. Y., Keene, D. R., Ono, R., Reinhardt, D. P., Sakai, L. Y., Biery, N. J., Bunton, T., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-218 · Cited by 407
Self-citationImmunohistologic Abnormalities of the Microfibrillar-Fiber System in the Marfan Syndrome
Hollister, D. W., Godfrey, M., Sakai, L. Y., & Pyeritz, R. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230303 · Cited by 397
Self-citationBunton, T. E., Biery, N. J., Myers, L., Gayraud, B., Ramirez, F., & Dietz, H. C. (2001) · Circulation Research · doi:10.1161/01.res.88.1.37 · Cited by 367
Self-citationDietz, H. C., McIntosh, I., Sakai, L. Y., Corson, G. M., Chalberg, S. C., Pyeritz, R. E., & Francomano, C. A. (1993) · Genomics · doi:10.1006/geno.1993.1349 · Cited by 306
Self-citationSakai, L. Y., Keene, D. R., Glanville, R. W., & Bächinger, H. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98752-1 · Cited by 288
Self-citationFibrillin-1: Organization in Microfibrils and Structural Properties
Reinhardt, D. P., Keene, D. R., Corson, G. M., Pöschl, E., Bächinger, H. P., Gambee, J. E., & Sakai, L. Y. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0237 · Cited by 253
Self-citationNijbroek, G., Sood, S., McIntosh, I., Francomano, C. A., Bull, E., Pereira, L. V., Ramirez, F., Pyeritz, R. E., & Dietz, H. C. (1995) · PubMed · Cited by 233
Self-citationSchrijver, I., Liu, W., Brenn, T., Furthmayr, H., & Francke, U. (1999) · The American Journal of Human Genetics · doi:10.1086/302582 · Cited by 225
Ultrastructural studies on early elastogenesis
Fahrenbach, W. H., Sandberg, L. B., & Cleary, E. G. (1966) · The Anatomical Record · doi:10.1002/ar.1091550409 · Cited by 222
Interactions of Fibrillin-1 with Heparin/Heparan Sulfate, Implications for Microfibrillar Assembly
Tiedemann, K., Bätge, B., Müller, P. K., & Reinhardt, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104985200 · Cited by 172
Schrijver, I., Liu, W., Odom, R., Brenn, T., Oefner, P., Furthmayr, H., & Francke, U. (2002) · The American Journal of Human Genetics · doi:10.1086/341581 · Cited by 165
Calcium Stabilizes Fibrillin-1 against Proteolytic Degradation
Reinhardt, D. P., Ono, R. N., & Sakai, L. Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1231 · Cited by 156
Self-citationThe Supramolecular Organization of Fibrillin-Rich Microfibrils
Baldock, C., Koster, A. J., Ziese, U., Rock, M. J., Sherratt, M. J., Kadler, K. E., Shuttleworth, C. A., & Kielty, C. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1045 · Cited by 152
Trask, T. M., Trask, B. C., Ritty, T. M., Abrams, W. R., Rosenbloom, J., & Mecham, R. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003665200 · Cited by 134
Charbonneau, N. L., Dzamba, B. J., Ono, R. N., Keene, D. R., Corson, G. M., Reinhardt, D. P., & Sakai, L. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209201200 · Cited by 130
Self-citationHutchinson, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg241 · Cited by 122
Reinhardt, D. P., Ono, R. N., Notbohm, H., Müller, P. K., Bächinger, H. P., & Sakai, L. Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12339 · Cited by 117
Self-citationLiu, W., Oefner, P. J., Qian, C., Odom, R. S., & Francke, U. (1997) · Genetic Testing · doi:10.1089/gte.1997.1.237 · Cited by 114
Ascertainment and severity of Marfan syndrome in a Scottish population.
Gray, J., Bridges, A. B., Faed, M. J. W., Pringle, T., Baines, P. S., Dean, J., & Boxer, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.1.51 · Cited by 111
Marfan Database (third edition): new mutations and new routines for the software
Collod‐Béroud, G., Béroud, C., Ades, L., Black, C., Boxer, M., Brock, D. J., Holman, K. J., de Paepe, A., Francke, U., Grau, U., et al. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.229 · Cited by 107
Handford, P. A., Downing, A. K., Rao, Z., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6751 · Cited by 105
Godfrey, M., Menashe, V. D., Weleber, R. G., Koler, R. D., Bigley, R. H., LOVRIEN, E. W., Zonana, J., & Hollister, D. W. (1990) · Europe PMC (PubMed Central) · Cited by 93
ELDADAH, Z. A., Brenn, T., Furthmayr, H., & Dietz, H. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117737 · Cited by 92
Self-citation[2] Fibrillin: Monomers and microfibrils
Sakai, L. Y., & Keene, D. R. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)45004-8 · Cited by 92
Self-citationGayraud-Morel, B., Keene, D. R., Sakai, L. Y., & Ramirez, F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.3.667 · Cited by 89
Self-citationYeast kar1 Mutants Provide an Effective Method for YAC Transfer to New Hosts
Spencer, F. A., Hugerat, Y., Simchen, G., Hurko, O., Connelly, C. J., & Hieter, P. (1994) · Genomics · doi:10.1006/geno.1994.1352 · Cited by 78
Trask, T. M., Ritty, T. M., Broekelmann, T. J., Tisdale, C., & Mecham, R. P. (1999) · Biochemical Journal · doi:10.1042/bj3400693 · Cited by 75
Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts
Raghunath, M., Superti‐Furga, A., Godfrey, M., & Steinmann, B. U. (1993) · Human Genetics · doi:10.1007/bf00217450 · Cited by 66
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome.
Godfrey, M., Olson, S., Burgio, R., Martini, A., Valli, M., Cetta, G., Hori, H., & Hollister, D. W. (1990) · Europe PMC (PubMed Central) · Cited by 53
Kainulainen, K., Steinmann, B. U., Collins, F. S., Dietz, H. C., Francomano, C. A., Child, A. H., Kilpatrick, M. W., Brock, D. J. H., Keston, M., & Pyeritz, R. E. (1991) · Europe PMC (PubMed Central) · Cited by 52
Self-citationThe question of heterogeneity in Marfan syndrome
Dietz, H. C., Francke, U., Furthmayr, H., Francomano, C. A., Paepe, A. D., Devereux, R. B., Ramirez, F., & Pyeritz, R. E. (1995) · Nature Genetics · doi:10.1038/ng0395-228 · Cited by 50
Self-citationHindson, V. J., Ashworth, J. L., Rock, M. J., Cunliffe, S. L., Shuttleworth, C. A., & Kielty, C. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00623-7 · Cited by 43
Fibrillin secretion and microfibril assembly by Marfan dermal fibroblasts
Kielty, C. M., Phillips, J. E., Child, A. H., Pope, F. M., & Shuttleworth, C. A. (1994) · Matrix Biology · doi:10.1016/0945-053x(94)90008-6 · Cited by 33
Differential allelic expression of a fibrillin gene (FBN1) in patients with Marfan syndrome.
Hewett, D. R., Lynch, J. R., Child, A. H., Firth, H. J., & Sykes, B. C. (1994) · Europe PMC (PubMed Central) · Cited by 31
Cited by
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Self-citationTGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology
Morikawa, M., Derynck, R., & Miyazono, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021873 · Cited by 1,321
Judge, D. P., & Dietz, H. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67789-6 · Cited by 1,210
Self-citationExtracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 669
Self-citation
Metadata
- Authors
- Judge, D. P., Biery, N. J., Keene, D. R., Geubtner, J., Myers, L., Huso, D. L., Sakai, L. Y., & Dietz, H. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-15
- Volume
- 114
- Issue
- 2
- Pages
- 172-181
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2136335783
- Cited by
- 475
- References
- 43
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.